Analyze Diet
Journal of veterinary internal medicine2019; 34(1); 300-306; doi: 10.1111/jvim.15685

Antimicrobial susceptibility of bacterial isolates from ambulatory practice and from a referral hospital.

Abstract: Responsible use of antimicrobials in equine practice relies on knowledge of common bacterial isolates and their antimicrobial sensitivities. Objective: To assess the frequency of bacterial resistance to a combination of parenteral penicillin and gentamicin and to trimethoprim and sulfamethoxazole for PO use in a selection of clinical isolates, and subsequently to determine the prevalence of resistance to antimicrobials that might then be used as alternatives to first-line antimicrobials for the same isolates. Methods: Retrospective analysis of minimal inhibitory concentrations (MICs) of antimicrobials for 6354 bacterial isolates from 365 ambulatory practices and 519 isolates from a referral hospital. The MICs were used to indicate sensitivity or resistance to commonly used antimicrobials and the prevalences of resistance were compared between origin of the isolates, and among antimicrobial drugs. Results: Isolates from the referral hospital were significantly (P < .05) more likely to be resistant to the antimicrobials tested than those derived from ambulatory practice. Overall, 91% of the ambulatory isolates and 64% of the hospital isolates were sensitive to penicillin-gentamicin. For trimethoprim-sulfamethoxazole combination, 82% of the ambulatory practice isolates and 56% of the referral hospital isolates were sensitive. Conclusions: Most isolates were sensitive to penicillin and gentamicin as well as trimethoprim-sulfamethoxazole. No predictable efficacious second choice antimicrobial was identified for those isolates resistant to the first-line antimicrobials. The likelihood of isolates being sensitive to second choice antimicrobials was variable but generally higher for ambulatory isolates compared to referral isolates. Bacterial identification and measurement of MIC are essential to make the appropriate antimicrobial choice.
Publication Date: 2019-12-17 PubMed ID: 31849110PubMed Central: PMC6979268DOI: 10.1111/jvim.15685Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the evaluation of bacterial resistance to common antimicrobial drugs used in equine practice. It found that a majority of bacterial isolates were sensitive to the primary antimicrobial, with a higher resistance observed in organisms originating from a referral hospital compared to those from ambulatory practices.

Objective and Methodology

  • The primary purpose of the study was to assess the resistance of common bacterial isolates to popular antimicrobials used in equine care, thereby informing sound antimicrobial utilization.
  • It aimed to gauge the effectiveness of combination drugs such as parenteral penicillin and gentamicin, and trimethoprim with sulfamethoxazole. It also sought to determine suitable alternative antimicrobials in case of resistance to the first-line drugs.
  • The investigation executed a retrospective analysis of antimicrobial minimal inhibitory concentrations (MICs) for bacterial isolates measures the amount of an antimicrobial substance that inhibits growth of these organisms.
  • A vast range of isolates were tested – 6354 from 365 ambulatory practices and 519 from a referral hospital. These MIC figures were then deployed to deduce resistance or sensitivity to the drugs in question.

    Results

    • The study discovered that isolates originating from the referral hospital were noticeably more resistant to the tested antimicrobials than those from ambulatory practices, with the difference in resistance levels being statistically significant.
    • In terms of sensitivity to the penicillin-gentamicin combo, about 91% of the isolates from ambulatory practices and 64% from the hospital showed a positive response.
    • When switching to the use of trimethoprim with sulfamethoxazole, the sensitivity rates stood at 82% (ambulatory practices) and 56% (referrals).

      Conclusions

      • The authors found most of the bacterial isolates to be sensitive to primary antimicrobials i.e. penicillin and gentamicin, and trimethoprim-sulfamethoxazole.
      • However, they were unable to identify a consistently effective second-choice antimicrobial for those isolates that proved resistant to first-line antimicrobials.
      • The prospect of isolate sensitivity to secondary antimicrobials was found to be variable, with a typically higher likelihood in ambulatory specimens than referral specimens.
      • The research underlines the critical importance of bacterial identification and accurate MIC measurement for making the most suitable choice of antimicrobial.

Cite This Article

APA
Potier JFN, Durham AE. (2019). Antimicrobial susceptibility of bacterial isolates from ambulatory practice and from a referral hospital. J Vet Intern Med, 34(1), 300-306. https://doi.org/10.1111/jvim.15685

Publication

ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 34
Issue: 1
Pages: 300-306

Researcher Affiliations

Potier, Julie F N
  • The Liphook Equine Hospital, Hampshire, United Kingdom.
Durham, Andy E
  • The Liphook Equine Hospital, Hampshire, United Kingdom.

MeSH Terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Bacteria / drug effects
  • Drug Resistance, Bacterial
  • Hospitals, Animal
  • Retrospective Studies

Conflict of Interest Statement

Authors declare no conflict of interest.

References

This article includes 30 references
  1. Walther B, Tedin K, Lübke-Becker A. Multidrug-resistant opportunistic pathogens challenging veterinary infection control.. Vet Microbiol 2017 Feb;200:71-78.
    pubmed: 27291944doi: 10.1016/j.vetmic.2016.05.017google scholar: lookup
  2. Dunowska M, Morley PS, Traub-Dargatz JL, Hyatt DR, Dargatz DA. Impact of hospitalization and antimicrobial drug administration on antimicrobial susceptibility patterns of commensal Escherichia coli isolated from the feces of horses.. J Am Vet Med Assoc 2006 Jun 15;228(12):1909-17.
    pubmed: 16784384doi: 10.2460/javma.228.12.1909google scholar: lookup
  3. Sieber S, Gerber V, Jandova V, Rossano A, Evison JM, Perreten V. Evolution of multidrug-resistant Staphylococcus aureus infections in horses and colonized personnel in an equine clinic between 2005 and 2010.. Microb Drug Resist 2011 Sep;17(3):471-8.
    pubmed: 21875361doi: 10.1089/mdr.2010.0188google scholar: lookup
  4. Jethwa S. Principles of initiating antimicrobial therapy and empiric prescribing.. Clinic Pharma 2016;8(8):1‐7.
  5. Hughes LA, Pinchbeck G, Callaby R, Dawson S, Clegg P, Williams N. Antimicrobial prescribing practice in UK equine veterinary practice.. Equine Vet J 2013 Mar;45(2):141-7.
  6. De Briyne N, Atkinson J, Pokludová L, Borriello SP. Antibiotics used most commonly to treat animals in Europe.. Vet Rec 2014 Oct 4;175(13):325.
    pmc: PMC4215272pubmed: 24899065doi: 10.1136/vr.102462google scholar: lookup
  7. Weese JS. Antimicrobial use and antimicrobial resistance in horses.. Equine Vet J 2015 Nov;47(6):747-9.
    pubmed: 26475768doi: 10.1111/evj.12469google scholar: lookup
  8. Schwarz S, Silley P, Simjee S, Woodford N, van Duijkeren E, Johnson AP, Gaastra W. Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals.. J Antimicrob Chemother 2010 Apr;65(4):601-4.
    pubmed: 20181573doi: 10.1093/jac/dkq037google scholar: lookup
  9. Durham AE. An evaluation of serum gentamicin concentrations and bacterial susceptibility to gentamicin in equine practice.. J Vet Intern Med 2018 May;32(3):1194-1201.
    pmc: PMC5980452pubmed: 29575239doi: 10.1111/jvim.15078google scholar: lookup
  10. Mouton JW, Brown DF, Apfalter P, Cantón R, Giske CG, Ivanova M, MacGowan AP, Rodloff A, Soussy CJ, Steinbakk M, Kahlmeter G. The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach.. Clin Microbiol Infect 2012 Mar;18(3):E37-45.
  11. Humphries RM, Ambler J, Mitchell SL, Castanheira M, Dingle T, Hindler JA, Koeth L, Sei K. CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests.. J Clin Microbiol 2018 Apr;56(4).
    pmc: PMC5869819pubmed: 29367292doi: 10.1128/jcm.01934-17google scholar: lookup
  12. Toutain PL, Bousquet-Mélou A, Damborg P, Ferran AA, Mevius D, Pelligand L, Veldman KT, Lees P. En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach.. Front Microbiol 2017;8:2344.
    pmc: PMC5736858pubmed: 29326661doi: 10.3389/fmicb.2017.02344google scholar: lookup
  13. Langston VC, Sedrish S, Boothe DM. Disposition of single-dose oral enrofloxacin in the horse.. J Vet Pharmacol Ther 1996 Aug;19(4):316-9.
  14. Dunkel B, Johns IC. Antimicrobial use in critically ill horses.. J Vet Emerg Crit Care (San Antonio) 2015 Jan-Feb;25(1):89-100.
    pubmed: 25582245doi: 10.1111/vec.12275google scholar: lookup
  15. Johns I, Verheyen K, Good L, Rycroft A. Antimicrobial resistance in faecal Escherichia coli isolates from horses treated with antimicrobials: a longitudinal study in hospitalised and non-hospitalised horses.. Vet Microbiol 2012 Oct 12;159(3-4):381-9.
    pubmed: 22565010doi: 10.1016/j.vetmic.2012.04.010google scholar: lookup
  16. Kuper KM, Boles DM, Mohr JF, Wanger A. Antimicrobial susceptibility testing: a primer for clinicians.. Pharmacotherapy 2009 Nov;29(11):1326-43.
    pubmed: 19857149doi: 10.1592/phco.29.11.1326google scholar: lookup
  17. Wagenlehner FM, Hoyme U, Kaase M, Fünfstück R, Naber KG, Schmiemann G. Uncomplicated urinary tract infections.. Dtsch Arztebl Int 2011 Jun;108(24):415-23.
    pmc: PMC3132618pubmed: 21776311doi: 10.3238/arztebl.2011.0415google scholar: lookup
  18. Ahlmén J, Brorson JE. Pharmacokinetics of trimethoprim given in single daily doses for three days.. Scand J Infect Dis 1982;14(2):143-5.
    pubmed: 7100826doi: 10.3109/inf.1982.14.issue-2.14google scholar: lookup
  19. Gasthuys F, Pockelé K, Vervaet C, Weyenberg W, De Prijck K, Pille F, Vlaminck L, Nelis H, Remon JP. Evaluation of the in vivo behaviour of gentamicin sulphate ocular mini-tablets in ponies.. J Vet Pharmacol Ther 2007 Oct;30(5):470-6.
  20. Barr BS, Waldridge BM, Morresey PR, Reed SM, Clark C, Belgrave R, Donecker JM, Weigel DJ. Antimicrobial-associated diarrhoea in three equine referral practices.. Equine Vet J 2013 Mar;45(2):154-8.
  21. Doern CD. When does 2 plus 2 equal 5? A review of antimicrobial synergy testing.. J Clin Microbiol 2014 Dec;52(12):4124-8.
    pmc: PMC4313275pubmed: 24920779doi: 10.1128/jcm.01121-14google scholar: lookup
  22. Yeh P, Tschumi AI, Kishony R. Functional classification of drugs by properties of their pairwise interactions.. Nat Genet 2006 Apr;38(4):489-94.
    pubmed: 16550172doi: 10.1038/ng1755google scholar: lookup
  23. Wagner C, Sauermann R, Joukhadar C. Principles of antibiotic penetration into abscess fluid.. Pharmacology 2006;78(1):1-10.
    pubmed: 16864973doi: 10.1159/000094668google scholar: lookup
  24. Stewart PS. Antimicrobial tolerance in biofilms.. Microb Spectrum 2015;3(3):10‐23.
  25. Hall CW, Mah TF. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria.. FEMS Microbiol Rev 2017 May 1;41(3):276-301.
    pubmed: 28369412doi: 10.1093/femsre/fux010google scholar: lookup
  26. Bollenbach T. Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution.. Curr Opin Microbiol 2015 Oct;27:1-9.
    pubmed: 26042389doi: 10.1016/j.mib.2015.05.008google scholar: lookup
  27. Lázár V, Pal Singh G, Spohn R, Nagy I, Horváth B, Hrtyan M, Busa-Fekete R, Bogos B, Méhi O, Csörgő B, Pósfai G, Fekete G, Szappanos B, Kégl B, Papp B, Pál C. Bacterial evolution of antibiotic hypersensitivity.. Mol Syst Biol 2013 Oct 29;9:700.
    pmc: PMC3817406pubmed: 24169403doi: 10.1038/msb.2013.57google scholar: lookup
  28. Torella JP, Chait R, Kishony R. Optimal drug synergy in antimicrobial treatments.. PLoS Comput Biol 2010 Jun 3;6(6):e1000796.
  29. Chait R, Craney A, Kishony R. Antibiotic interactions that select against resistance.. Nature 2007 Apr 5;446(7136):668-71.
    pubmed: 17410176doi: 10.1038/nature05685google scholar: lookup
  30. Guardabassi L, Apley M, Olsen JE, Toutain PL, Weese S. Optimization of Antimicrobial Treatment to Minimize Resistance Selection.. Microbiol Spectr 2018 May;6(3).

Citations

This article has been cited 2 times.
  1. Garland A, van Doorn DA, van den Boom R, Roelfsema E, Jung L, Boast M, Papadakis K, Margiotta M, Wafelbakker S, Briggs M, McCrae P, Pearson W. Morphometric changes in overweight horses following 10-week weight loss programs. BMC Vet Res 2025 Oct 10;21(1):596.
    doi: 10.1186/s12917-025-05032-zpubmed: 41068901google scholar: lookup
  2. Hallowell KL, Hepworth-Warren KL, Dembek K. An updated description of bacterial pneumonia in adult horses and factors associated with death. J Vet Intern Med 2024 Sep-Oct;38(5):2766-2775.
    doi: 10.1111/jvim.17141pubmed: 39005215google scholar: lookup